All Stories

  1. Placental growth factor inhibition targets pulmonary angiogenesis and represents a novel therapy for hepatopulmonary syndrome in mice

    Article • Hepatology, May 2018, Wiley

    Prof. Dr. Ken R Bracke, Xavier Verhelst

  2. Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history

    Article • Hepatology, April 2018, Wiley

    Xavier Verhelst, Professor Albert Pares

  3. Severe Hepatic and Pulmonary Involvement in Rendu-Osler-Weber Syndrome

    Article • Case Reports in Gastroenterology, January 2018, Karger Publishers

    Xavier Verhelst

  4. Refractory subacute steatohepatitis after biliopancreatic diversion

    Article • Hepatology, May 2017, Wiley

    Xavier Verhelst

  5. Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease

    Article • International Journal of Obesity, May 2017, Nature

    Xavier Verhelst

  6. Modulation of the Unfolded Protein Response by Tauroursodeoxycholic Acid Counteracts Apoptotic Cell Death and Fibrosis in a Mouse Model for Secondary Biliary Liver Fibrosis

    Article • International Journal of Molecular Sciences, January 2017, MDPI AG

    Xavier Verhelst

  7. A Glycomics-Based Test Predicts the Development of Hepatocellular Carcinoma in Cirrhosis

    Article • Clinical Cancer Research, December 2016, American Association for Cancer Research (AACR)

    Xavier Verhelst

  8. Combination of tauroursodeoxycholic acid and N-acetylcysteine exceeds standard treatment for acetaminophen intoxication

    Article • Liver International, October 2016, Wiley

    Xavier Verhelst

  9. Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity

    Article • Obesity, October 2016, Wiley

    Xavier Verhelst

  10. Comments on the impact of genotyping method on the subtype distribution of HCV genotype 1

    Article • Journal of Clinical Virology, October 2016, Elsevier

    Xavier Verhelst

  11. Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form

    Article • International Journal of Molecular Sciences, August 2016, MDPI AG

    Xavier Verhelst

  12. Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease

    Article • Cellular and Molecular Life Sciences, April 2016, Springer Science + Business Media

    Xavier Verhelst

  13. Longitudinal Transient Elastography Measurements Used in Follow-up for Patients with Cystic Fibrosis

    Article • Ultrasound in Medicine & Biology, April 2016, Elsevier

    Xavier Verhelst

  14. The role of macrophages in obesity-driven chronic liver disease

    Article • Journal of Leukocyte Biology, March 2016, Society for Leukocyte Biology

    Xavier Verhelst

  15. Successful Treatment of HCV-associated B-Cell Non-Hodgkin Lymphomas With Direct-acting Antiviral Agents

    Article • Journal of Clinical Gastroenterology, February 2016, Wolters Kluwer Health

    Xavier Verhelst

  16. Placental growth factor inhibition modulates the interplay between hypoxia and unfolded protein response in hepatocellular carcinoma

    Article • BMC Cancer, January 2016, Springer Science + Business Media

    Xavier Verhelst

  17. Quality of life after liver transplantation: State of the art

    Article • World Journal of Hepatology, January 2016, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Xavier Verhelst

  18. Association of recently described adipokines with liver histology in biopsy-proven non-alcoholic fatty liver disease: a systematic review

    Article • Obesity Reviews, November 2015, Wiley

    Xavier Verhelst

  19. Tauroursodeoxycholic acid dampens oncogenic apoptosis induced by endoplasmic reticulum stress during hepatocarcinogen exposure

    Article • Oncotarget, September 2015, Impact Journals, LLC

    Xavier Verhelst

  20. Intramuscular hepatitis B immunoglobulins for reinfection control after liver transplantation: a cost-saving alternative

    Article • Journal of Comparative Effectiveness Research, May 2015, Future Medicine

    Xavier Verhelst

  21. Time-Dependent Effect of Hypoxia on Tumor Progression and Liver Progenitor Cell Markers in Primary Liver Tumors

    Article • PLoS ONE, March 2015, PLOS

    Xavier Verhelst

  22. Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment

    Article • Liver International, February 2015, Wiley

    Xavier Verhelst

  23. Next-generation proteasome inhibitor oprozomib synergizes with modulators of the unfolded protein response to suppress hepatocellular carcinoma

    Article • Oncotarget, November 2014, Impact Journals, LLC

    Xavier Verhelst

  24. Modulation of the unfolded protein response impedes tumor cell adaptation to proteotoxic stress: a PERK for hepatocellular carcinoma therapy

    Article • Hepatology International, October 2014, Springer Science + Business Media

    Xavier Verhelst

  25. Therapeutic effects of artesunate in hepatocellular carcinoma

    Article • European Journal of Gastroenterology & Hepatology, August 2014, Wolters Kluwer Health

    Xavier Verhelst

  26. Role of angiogenic factors/cell adhesion markers in serum of cirrhotic patients with hepatopulmonary syndrome

    Article • Liver International, May 2014, Wiley

    Xavier Verhelst

  27. Cerebellar stroke in a low cardiovascular risk patient associated with sorafenib treatment for fibrolamellar hepatocellular carcinoma

    Article • Clinical Case Reports, December 2013, Wiley

    Xavier Verhelst

  28. Oral vasodilator therapy in patients with moderate to severe portopulmonary hypertension as a bridge to liver transplantation

    Article • European Journal of Gastroenterology & Hepatology, April 2013, Wolters Kluwer Health

    Xavier Verhelst

  29. Pathophysiology and Management of Post Resection Liver Failure

    Article • Acta Chirurgica Belgica, January 2013, Taylor & Francis

    Xavier Verhelst

  30. Biomarkers for the diagnosis of acute cellular rejection in liver transplant recipients: A review

    Article • Hepatology Research, November 2012, Wiley

    Xavier Verhelst

  31. A case of emphysematous gastritis

    Article • Endoscopy, May 2012, Thieme Publishing Group

    Xavier Verhelst

  32. Progressive multifocal leukoencephalopathy in liver transplant recipients: a case report and review of the literature

    Article • Transplant International, December 2010, Wiley

    Xavier Verhelst

  33. Subfulminant hepatitis B during treatment with adalimumab in a patient with rheumatoid arthritis and chronic hepatitis B

    Article • European Journal of Gastroenterology & Hepatology, April 2010, Wolters Kluwer Health

    Xavier Verhelst

  34. Leflunomide and methotrexate combination therapy in daily clinical practice

    Article • Annals of the Rheumatic Diseases, June 2006, BMJ

    Xavier Verhelst

  35. Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis

    Article • Annals of the Rheumatic Diseases, February 2005, BMJ

    Xavier Verhelst